These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19763147)
1. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo. Ardiani A; Sanchez-Bonilla M; Black ME Cancer Gene Ther; 2010 Feb; 17(2):86-96. PubMed ID: 19763147 [TBL] [Abstract][Full Text] [Related]
2. A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing. Willmon CL; Krabbenhoft E; Black ME Gene Ther; 2006 Sep; 13(17):1309-12. PubMed ID: 16810197 [TBL] [Abstract][Full Text] [Related]
3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
4. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer. Zhang JH; Wan MX; Pan BR; Yu B Cancer Biol Ther; 2004 Nov; 3(11):1075-80. PubMed ID: 15477756 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
7. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Kim YG; Bi W; Feliciano ES; Drake RR; Stambrook PJ Cancer Gene Ther; 2000 Feb; 7(2):240-6. PubMed ID: 10770632 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Kokoris MS; Sabo P; Adman ET; Black ME Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366 [TBL] [Abstract][Full Text] [Related]
9. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer. Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746 [TBL] [Abstract][Full Text] [Related]
10. Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice. Castillo-Rodríguez RA; Arango-Rodríguez ML; Escobedo L; Hernandez-Baltazar D; Gompel A; Forgez P; Martínez-Fong D PLoS One; 2014; 9(5):e97151. PubMed ID: 24824754 [TBL] [Abstract][Full Text] [Related]
11. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas. Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794 [TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo. Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181 [TBL] [Abstract][Full Text] [Related]
14. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells. Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379 [TBL] [Abstract][Full Text] [Related]
15. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C; Bergeron C; Lane D; Garon G; Piché A Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047 [TBL] [Abstract][Full Text] [Related]
16. Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect. Preuss E; Muik A; Weber K; Otte J; von Laer D; Fehse B J Mol Med (Berl); 2011 Nov; 89(11):1113-24. PubMed ID: 21698427 [TBL] [Abstract][Full Text] [Related]
17. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect. Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395 [TBL] [Abstract][Full Text] [Related]
18. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Shibata MA; Morimoto J; Otsuki Y Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241 [TBL] [Abstract][Full Text] [Related]